UFT for head and neck cancers: its tissu
β
Masayoshi Tachibana; Norio Yasuda; Masaki Yoshimatsu; Hideo Nishimura; Osamu Miz
π
Article
π
1987
π
Springer
π
English
β 310 KB
UFT, a combination of the masked compound of 5-fluorouracil (FT-207) and uracil, was given to head and neck cancer patients for 1 week preoperatively and for 8 weeks postoperatively. Drug concentrations were examined in the surgically removed tissues. The concentrations of FT-207, 5-fluorouracil, an